PEOPLE - VidaMed (US) president and Chief Executive Officer to resign:
This article was originally published in Clinica
Executive Summary
James Heisch is to resign as president and CEO of VidaMed, a US manufacturer of advanced systems for the treatment of urological conditions. Mr Heisch said it was now time for VidaMed to recruit a seasoned medical-device executive who would lead the company in the launch of its transurethral ablation system (TUNA) for the treatment of benign prostatic hyperplasia. The system is already FDA-approved.